메뉴 건너뛰기




Volumn 151, Issue 4, 2006, Pages 771-778

A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: There remains an unmet need

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHYROID AGENT; DILTIAZEM; DISOPYRAMIDE; GAP JUNCTION PROTEIN; PROPAFENONE; QUINIDINE; SEROTONIN; SOTALOL; WARFARIN;

EID: 33645211728     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.06.014     Document Type: Review
Times cited : (50)

References (60)
  • 1
    • 0042244159 scopus 로고    scopus 로고
    • Atrial fibrillation: Classification, pathophysiology, mechanisms and drug treatment
    • V. Markides, and R.J. Schilling Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment Heart 89 2003 939 943
    • (2003) Heart , vol.89 , pp. 939-943
    • Markides, V.1    Schilling, R.J.2
  • 2
    • 0027440556 scopus 로고
    • Atrial fibrillation: Current understanding and research imperatives
    • The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation
    • The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation Atrial fibrillation: current understanding and research imperatives J Am Coll Cardiol 22 1993 1830 1834
    • (1993) J Am Coll Cardiol , vol.22 , pp. 1830-1834
  • 3
    • 0035940379 scopus 로고    scopus 로고
    • ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary
    • V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary Circulation 104 2001 2118 2150
    • (2001) Circulation , vol.104 , pp. 2118-2150
    • Fuster, V.1    Ryden, L.E.2    Asinger, R.W.3
  • 4
    • 4143064759 scopus 로고    scopus 로고
    • Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: The results of the Polish How to Treat Chronic Atrial Fibrillation Study
    • G. Opolski, A. Torbicki, and D.A. Kosior Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How To Treat Chronic Atrial Fibrillation Study Chest 126 2004 476 486
    • (2004) Chest , vol.126 , pp. 476-486
    • Opolski, G.1    Torbicki, A.2    Kosior, D.A.3
  • 5
    • 0038025290 scopus 로고    scopus 로고
    • Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study
    • J. Carlsson, S. Miketic, and J. Windeler Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1690-1696
    • Carlsson, J.1    Miketic, S.2    Windeler, J.3
  • 6
    • 0037028033 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
    • I.C. van Gelder, V.E. Hagens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
    • (2002) N Engl J Med , vol.347 , pp. 1834-1840
    • Van Gelder, I.C.1    Hagens, V.E.2    Bosker, H.A.3
  • 7
    • 0037028022 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with atrial fibrillation
    • The AFFIRM Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
    • (2002) N Engl J Med , vol.347 , pp. 1825-1833
    • Affirm Investigators, T.1
  • 8
    • 0034715973 scopus 로고    scopus 로고
    • Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial
    • S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial Lancet 356 2000 1789 1794
    • (2000) Lancet , vol.356 , pp. 1789-1794
    • Hohnloser, S.H.1    Kuck, K.H.2    Lilienthal, J.3
  • 9
    • 1842434297 scopus 로고    scopus 로고
    • Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study
    • The AFFIRM Investigators Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513
    • (2004) Circulation , vol.109 , pp. 1509-1513
    • Affirm Investigators, T.1
  • 10
    • 0035902567 scopus 로고    scopus 로고
    • Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function
    • O.D. Pederson, H. Bagger, and N. Keller Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function Circulation 194 2001 292 296
    • (2001) Circulation , vol.194 , pp. 292-296
    • Pederson, O.D.1    Bagger, H.2    Keller, N.3
  • 11
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 12
    • 0032497292 scopus 로고    scopus 로고
    • Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
    • E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
    • (1998) Circulation , vol.98 , pp. 946-952
    • Benjamin, E.J.1    Wolf, P.A.2    D'Agostino, R.B.3
  • 13
    • 1342301530 scopus 로고    scopus 로고
    • Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK
    • S. Stewart, N. Murphy, and A. Walker Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 2004 286 292
    • (2004) Heart , vol.90 , pp. 286-292
    • Stewart, S.1    Murphy, N.2    Walker, A.3
  • 14
    • 0038208383 scopus 로고    scopus 로고
    • Quality of life evidence in the management of the individual patient with atrial fibrillation
    • B. Luderitz Quality of life evidence in the management of the individual patient with atrial fibrillation Card Electrophysiol Rev 7 2003 6062
    • (2003) Card Electrophysiol Rev , vol.7 , pp. 6062
    • Luderitz, B.1
  • 16
    • 0036797537 scopus 로고    scopus 로고
    • A population-based study of the long-term risks associated with atrial fibrillation: 20 year follow-up of the Renfrew/Paisley Study
    • S. Stewart, C.L. Hart, and D.J. Hobe A population-based study of the long-term risks associated with atrial fibrillation: 20 year follow-up of the Renfrew/Paisley Study Am J Med 113 2002 359 364
    • (2002) Am J Med , vol.113 , pp. 359-364
    • Stewart, S.1    Hart, C.L.2    Hobe, D.J.3
  • 17
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults
    • A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults JAMA 285 2001 2370 2375
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3
  • 18
    • 0028921708 scopus 로고
    • Prevalence, age, distribution, and gender of patients with atrial fibrillation: Analysis and implications
    • W.M. Fineberg, J.L. Blackshear, and A. Lupacis Prevalence, age, distribution, and gender of patients with atrial fibrillation: analysis and implications Arch Intern Med 155 1995 469 473
    • (1995) Arch Intern Med , vol.155 , pp. 469-473
    • Fineberg, W.M.1    Blackshear, J.L.2    Lupacis, A.3
  • 19
    • 4844222283 scopus 로고    scopus 로고
    • Lifetime risk for development of atrial fibrillation: The Framingham Heart Study
    • D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
    • (2004) Circulation , vol.110 , pp. 1042-1046
    • Lloyd-Jones, D.M.1    Wang, T.J.2    Leip, E.P.3
  • 20
    • 0344826514 scopus 로고    scopus 로고
    • Rate vs rhythm control-an open and shut case?
    • G. Tomaselli Rate vs rhythm control-an open and shut case? Heart Drug 3 2003 125 126
    • (2003) Heart Drug , vol.3 , pp. 125-126
    • Tomaselli, G.1
  • 21
    • 0032498577 scopus 로고    scopus 로고
    • Impact of atrial fibrillation on mortality, stroke, and medical costs
    • P.A. Wolf, J.B. Mitchell, and C.S. Baker Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229 234
    • (1998) Arch Intern Med , vol.158 , pp. 229-234
    • Wolf, P.A.1    Mitchell, J.B.2    Baker, C.S.3
  • 22
    • 0043164965 scopus 로고    scopus 로고
    • Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention
    • W.A. Wattigny, G.A. Mensah, and J.B. Croft Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention Circulation 108 2003 711 776
    • (2003) Circulation , vol.108 , pp. 711-776
    • Wattigny, W.A.1    Mensah, G.A.2    Croft, J.B.3
  • 23
    • 0023625745 scopus 로고
    • Atrial fibrillation: A major contributor to stroke in the elderly. the Framingham Study
    • P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study Arch Intern Med 147 1987 1561 1564
    • (1987) Arch Intern Med , vol.147 , pp. 1561-1564
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 24
    • 0020964823 scopus 로고
    • Coronary heart disease and atrial fibrillation: The Framingham Study
    • W.B. Kannel, R.D. Abbott, and D.D. Savage Coronary heart disease and atrial fibrillation: the Framingham Study Am Heart J 106 1983 389 396
    • (1983) Am Heart J , vol.106 , pp. 389-396
    • Kannel, W.B.1    Abbott, R.D.2    Savage, D.D.3
  • 25
    • 0028299731 scopus 로고
    • Increased risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study
    • E.J. Benjamin, D. Levy, and S.M. Vaziri Increased risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study JAMA 82 1994 840 844
    • (1994) JAMA , vol.82 , pp. 840-844
    • Benjamin, E.J.1    Levy, D.2    Vaziri, S.M.3
  • 26
    • 0033593072 scopus 로고    scopus 로고
    • Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    • A.S. Go, E.M. Hylek, and L.H. Borowsky Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934
    • (1999) Ann Intern Med , vol.131 , pp. 927-934
    • Go, A.S.1    Hylek, E.M.2    Borowsky, L.H.3
  • 27
    • 0031053980 scopus 로고    scopus 로고
    • Is warfarin underused in the treatment of elderly persons with atrial fibrillation?
    • J. Whittle, L. Wickenheiser, and L.N. Venditti Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 157 1997 441 445
    • (1997) Arch Intern Med , vol.157 , pp. 441-445
    • Whittle, J.1    Wickenheiser, L.2    Venditti, L.N.3
  • 28
    • 0038185371 scopus 로고    scopus 로고
    • Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation
    • P. Peterson, M. Grind, and J. Adler Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation J Am Coll Cardiol 41 2003 1445 1451
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1445-1451
    • Peterson, P.1    Grind, M.2    Adler, J.3
  • 29
    • 0033576003 scopus 로고    scopus 로고
    • Atrial fibrillation in heart failure
    • W.G. Stevenson, and L.W. Stevenson Atrial fibrillation in heart failure [Editorial] N Engl J Med 341 1999 910 911
    • (1999) N Engl J Med , vol.341 , pp. 910-911
    • Stevenson, W.G.1    Stevenson, L.W.2
  • 30
    • 0032510395 scopus 로고    scopus 로고
    • Acute treatment of atrial fibrillation: Why and when to mention sinus rhythm
    • J.E. Waktare, and A.J. Camm Acute treatment of atrial fibrillation: why and when to mention sinus rhythm Am J Cardiol 81 1998 13c 15c
    • (1998) Am J Cardiol , vol.81
    • Waktare, J.E.1    Camm, A.J.2
  • 31
    • 0026718636 scopus 로고
    • Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
    • M. Grogan, H.C. Smith, and B.J. Gersh Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy Am J Cardiol 69 1992 1570 1573
    • (1992) Am J Cardiol , vol.69 , pp. 1570-1573
    • Grogan, M.1    Smith, H.C.2    Gersh, B.J.3
  • 32
    • 0026781316 scopus 로고
    • Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy
    • J.R. Kieny, A. Sacrez, and A. Facello Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy Eur Heart J 131 1992 1290 1295
    • (1992) Eur Heart J , vol.131 , pp. 1290-1295
    • Kieny, J.R.1    Sacrez, A.2    Facello, A.3
  • 33
    • 0023464081 scopus 로고
    • Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation
    • R. Lemery, P. Brugada, and E. Cheriex Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation Am J Cardiol 60 1987 1406 1408
    • (1987) Am J Cardiol , vol.60 , pp. 1406-1408
    • Lemery, R.1    Brugada, P.2    Cheriex, E.3
  • 34
    • 0035940379 scopus 로고    scopus 로고
    • ACC/AHA/ESC guidelines for the management of atrial fibrillation: Executive summary
    • V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC guidelines for the management of atrial fibrillation: executive summary Circulation 104 2001 2118 2150
    • (2001) Circulation , vol.104 , pp. 2118-2150
    • Fuster, V.1    Ryden, L.E.2    Asinger, R.W.3
  • 35
    • 0034765783 scopus 로고    scopus 로고
    • Quality of life in patients with silent atrial fibrillation
    • I. Savelieva, M. Paquette, and P. Dorian Quality of life in patients with silent atrial fibrillation Heart 85 2001 216 217
    • (2001) Heart , vol.85 , pp. 216-217
    • Savelieva, I.1    Paquette, M.2    Dorian, P.3
  • 36
    • 0031852644 scopus 로고    scopus 로고
    • Quality of life in patients with atrial fibrillation
    • W. Jung, and B. Luderitz Quality of life in patients with atrial fibrillation J Cardiovasc Electrophysiol 9 1998 s177 s186
    • (1998) J Cardiovasc Electrophysiol , vol.9
    • Jung, W.1    Luderitz, B.2
  • 37
    • 0028079536 scopus 로고
    • Treatment of atrial fibrillation in a district general hospital
    • G.Y. Lip, K.N. Tean, and F.G. Dunn Treatment of atrial fibrillation in a district general hospital Br Heart J 71 1994 92 95
    • (1994) Br Heart J , vol.71 , pp. 92-95
    • Lip, G.Y.1    Tean, K.N.2    Dunn, F.G.3
  • 38
    • 0007356262 scopus 로고    scopus 로고
    • Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators
    • D. Roy, M. Talajic, and P. Dorian Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators N Engl J Med 342 2000 913 920
    • (2000) N Engl J Med , vol.342 , pp. 913-920
    • Roy, D.1    Talajic, M.2    Dorian, P.3
  • 39
    • 0032819869 scopus 로고    scopus 로고
    • Management of atrial fibrillation: The need for AFFIRMative action
    • for the AFFIRM Investigators A.L.
    • A.L. Waldo for the AFFIRM Investigators Management of atrial fibrillation: the need for AFFIRMative action [Editorial] Am J Cardiol 84 1999 698 700
    • (1999) Am J Cardiol , vol.84 , pp. 698-700
    • Waldo1
  • 40
    • 0035902567 scopus 로고    scopus 로고
    • Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy
    • O.D. Pedersen, H. Bagger, and N. Keller Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy Circulation 104 2001 292 296
    • (2001) Circulation , vol.104 , pp. 292-296
    • Pedersen, O.D.1    Bagger, H.2    Keller, N.3
  • 41
    • 0037967287 scopus 로고    scopus 로고
    • Maintenance of sinus rhythm in patients with atrial fibrillation
    • The AFFIRM First Antiarrhythmic Drug Substudy Investigators Maintenance of sinus rhythm in patients with atrial fibrillation J Am Coll Cardiol 42 2003 20 29
    • (2003) J Am Coll Cardiol , vol.42 , pp. 20-29
  • 42
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    • R.G. Hart, O. Benavente, and R. McBride Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
    • (1999) Ann Intern Med , vol.131 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3
  • 43
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
    • A. Laupacis, G. Boysen, and S. Connolly Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials [erratum published in Arch Intern Med 154(1994)2254] Arch Intern Med 154 1994 1449 1457
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
    • Laupacis, A.1    Boysen, G.2    Connolly, S.3
  • 44
    • 0026752737 scopus 로고
    • Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study. the Flecainide Supraventricular Tachycardia Study Group
    • A.K. Bhandari, J.L. Anderson, and E.M. Gilbert Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group Am Heart J 124 1992 381 386
    • (1992) Am Heart J , vol.124 , pp. 381-386
    • Bhandari, A.K.1    Anderson, J.L.2    Gilbert, E.M.3
  • 45
    • 0037418332 scopus 로고    scopus 로고
    • Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide
    • R.L. Page, T.W. Tilsch, and S.J. Connolly Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide Circulation 107 2003 1141 1145
    • (2003) Circulation , vol.107 , pp. 1141-1145
    • Page, R.L.1    Tilsch, T.W.2    Connolly, S.J.3
  • 46
    • 0347228969 scopus 로고    scopus 로고
    • Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care
    • C.W. Israel, G. Grönefeld, and J.R. Ehrlich Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care J Am Coll Cardiol 43 2004 47 52
    • (2004) J Am Coll Cardiol , vol.43 , pp. 47-52
    • Israel, C.W.1    Grönefeld, G.2    Ehrlich, J.R.3
  • 47
    • 0031686381 scopus 로고    scopus 로고
    • Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction
    • D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695 703
    • (1998) J Am Coll Cardiol , vol.32 , pp. 695-703
    • Dries, D.L.1    Exner, D.V.2    Gersh, B.J.3
  • 48
    • 0036802853 scopus 로고    scopus 로고
    • Impact of atrial fibrillation on mortality in patients with chronic heart failure
    • M.P. Van den Berg, I.C. van Gelder, and D.J. van Veldhuisen Impact of atrial fibrillation on mortality in patients with chronic heart failure Eur J Heart Fail 4 2002 571 575
    • (2002) Eur J Heart Fail , vol.4 , pp. 571-575
    • Van Den Berg, M.P.1    Van Gelder, I.C.2    Van Veldhuisen, D.J.3
  • 49
    • 85008318951 scopus 로고    scopus 로고
    • Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial
    • The AF-CHF Investigators Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial Am Heart J 144 2002 597 607
    • (2002) Am Heart J , vol.144 , pp. 597-607
    • Af-Chf Investigators, T.1
  • 50
    • 3042857292 scopus 로고    scopus 로고
    • Advances in antiarrhythmic drug treatment of atrial fibrillation: Where do we stand now?
    • A.J. Camm, and I. Savelieva Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now? Heart Rhythm 1 2004 244 246
    • (2004) Heart Rhythm , vol.1 , pp. 244-246
    • Camm, A.J.1    Savelieva, I.2
  • 51
    • 0038300657 scopus 로고    scopus 로고
    • Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for curing atrial fibrillation
    • C. Pappone, S. Rosanio, and G. Augello Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for curing atrial fibrillation J Am Coll Cardiol 42 2003 185 197
    • (2003) J Am Coll Cardiol , vol.42 , pp. 185-197
    • Pappone, C.1    Rosanio, S.2    Augello, G.3
  • 52
    • 20144363969 scopus 로고    scopus 로고
    • Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation
    • R. Cappato, H. Calkins, and S.-A. Chen Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circulation 111 2005 1100 1105
    • (2005) Circulation , vol.111 , pp. 1100-1105
    • Cappato, R.1    Calkins, H.2    Chen, S.-A.3
  • 54
    • 7044234805 scopus 로고    scopus 로고
    • The who, what, why and how-to-guide for circumferential pulmonary vein ablation
    • C. Pappone, and V. Santinelli The who, what, why and how-to-guide for circumferential pulmonary vein ablation J Cardiovasc Electrophysiol 15 2004 1226 1230
    • (2004) J Cardiovasc Electrophysiol , vol.15 , pp. 1226-1230
    • Pappone, C.1    Santinelli, V.2
  • 56
    • 26444586727 scopus 로고    scopus 로고
    • Curative catheter ablation for atrial fibrillation
    • E. Good, and H. Oral Curative catheter ablation for atrial fibrillation Prog Cardiovasc Dis 2005 [in press]
    • (2005) Prog Cardiovasc Dis
    • Good, E.1    Oral, H.2
  • 57
    • 0242680329 scopus 로고    scopus 로고
    • Hybrid therapy of atrial fibrillation: Algorithms and outcomes
    • S. Saksena, and N. Madan Hybrid therapy of atrial fibrillation: algorithms and outcomes Interv Card Electrophysiol 9 2003 235 247
    • (2003) Interv Card Electrophysiol , vol.9 , pp. 235-247
    • Saksena, S.1    Madan, N.2
  • 58
    • 0032708031 scopus 로고    scopus 로고
    • AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: Effect on quality of life and exercise performance
    • A. Natale, L. Zimmerman, and G. Tomassini AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance Pacing Clin Electrophysiol 22 1999 1634 1639
    • (1999) Pacing Clin Electrophysiol , vol.22 , pp. 1634-1639
    • Natale, A.1    Zimmerman, L.2    Tomassini, G.3
  • 59
    • 7844219853 scopus 로고    scopus 로고
    • Atrioverter: An implantable device for the treatment of atrial fibrillation
    • H.J.J. Wellens, C.-P. Lau, and B. Luderitz Atrioverter: an implantable device for the treatment of atrial fibrillation Circulation 98 1998 1651 1656
    • (1998) Circulation , vol.98 , pp. 1651-1656
    • Wellens, H.J.J.1    Lau, C.-P.2    Luderitz, B.3
  • 60
    • 19844381460 scopus 로고    scopus 로고
    • Nonpharmacologic treatment of atrial fibrillation in elderly patients
    • R. Willems, and H. Heidbüchel Nonpharmacologic treatment of atrial fibrillation in elderly patients Am J Geriatr Cardiol 18 2005 68 72
    • (2005) Am J Geriatr Cardiol , vol.18 , pp. 68-72
    • Willems, R.1    Heidbüchel, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.